Dr. Wolf is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
550 Peachtree St
Ste 1600
Atlanta, GA 30308Phone+1 404-881-1094Fax+1 404-847-9792
Education & Training
- Cleveland Clinic FoundationFellowship, Gastroenterology, 1982 - 1984
- West Virginia UniversityResidency, Internal Medicine, 1979 - 1982
- West Virginia University School of MedicineClass of 1979
Certifications & Licensure
- GA State Medical License 1984 - 2025
- WV State Medical License 1980 - 1985
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Top MD Consumers Checkbook
- Fellow (FACG) American College of Gastroenterology
Clinical Trials
- Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis Start of enrollment: 2012 Feb 01
- Evaluation of a PillCam Colon Bowel Preparation Regimen in Crohn's Disease Patients Start of enrollment: 2012 Mar 01
- Evaluating a Shared Decision Making Program for Crohn's Disease Start of enrollment: 2014 Mar 01
Publications & Presentations
PubMed
- Impact of Prior Biologic Exposure on Ozanimod Efficacy and Safety in the Phase 3 True North Clinical Trial.Bruce E Sands, David T Rubin, Edward V Loftus Jr, Douglas C Wolf, Remo Panaccione
The American Journal of Gastroenterology. 2025-01-08 - 1 citationsWound Healing After Vaginal Delivery, Episiotomy, and Cesarean Section Delivery Among Women With IBD: Results From the PIANO Registry.Sara Lewin, Millie Long, Russell Cohen, Ellen Scherl, Douglas Wolf
Inflammatory Bowel Diseases. 2025-01-08 - 2 citationsImpact of Prior Biologic or Janus Kinase Inhibitor Therapy on Efficacy and Safety of Etrasimod in the ELEVATE UC 52 and ELEVATE UC 12 Trials.Séverine Vermeire, Bruce E Sands, Laurent Peyrin-Biroulet, Geert R D'Haens, Julian Panés
Journal of Crohn's & Colitis. 2024-11-04
Press Mentions
- A Cross-Sectional Study on the Determinants of Health-Related Quality of Life in the Philippines Using the EQ-5d-5lMarch 7th, 2021
- Defining What Constitutes an IBD Expert in PracticeAugust 21st, 2020
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: